Viewing Study NCT02768558


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-02-25 @ 11:02 PM
Study NCT ID: NCT02768558
Status: TERMINATED
Last Update Posted: 2021-06-02
First Post: 2016-05-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
Sponsor: RTOG Foundation, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-10-17
Start Date Type: ACTUAL
Primary Completion Date: 2019-01-23
Primary Completion Date Type: ACTUAL
Completion Date: 2019-01-23
Completion Date Type: ACTUAL
First Submit Date: 2016-05-06
First Submit QC Date: None
Study First Post Date: 2016-05-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-02-04
Results First Submit QC Date: None
Results First Post Date: 2020-02-25
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-05-12
Last Update Post Date: 2021-06-02
Last Update Post Date Type: ACTUAL